NOVOZYMES A S DKK 2.0 - COM

Historical Holders from Q1 2014 to Q3 2025

Type / Class
Equity / COM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
24,215
Holdings value
$1,477,379
% of all portfolios
0%
Number of holders
2
Number of sells
-2
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of NOVOZYMES A S DKK 2.0 - COM

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 24,215 $1,477,379 -$240,927 $61.01 2
2025 Q2 27,611 $1,976,013 +$264,508 $71.57 3
2025 Q1 23,915 $1,386,701 -$323,607 $57.98 2
2024 Q4 29,611 $1,672,027 -$573,260 $56.47 3
2024 Q3 37,745 $2,711,896 -$1,154,955 $71.85 5
2024 Q2 53,820 $3,283,963 -$547,631 $61.02 5
2024 Q1 62,795 $3,671,645 -$327,610 $58.47 5
2023 Q4 68,398 $3,748,994 -$659,143 $54.81 5
2023 Q3 82,070 $3,303,858 -$429,537 $40.26 6
2023 Q2 92,740 $4,307,328 -$708,738 $46.45 6
2023 Q1 107,439 $5,470,320 -$957,214 $50.92 7
2022 Q4 126,239 $6,374,772 -$1,350,573 $50.5 7
2022 Q3 152,989 $7,712,000 -$1,271,693 $50.41 8
2022 Q2 170,992 $10,243,000 -$3,895,304 $59.9 7
2022 Q1 235,102 $16,154,000 -$6,208,237 $68.72 8
2021 Q4 325,450 $26,678,000 -$9,371,895 $81.98 8
2021 Q3 439,773 $30,048,000 -$8,065,052 $68.33 8
2021 Q2 557,814 $41,951,000 -$13,168,994 $75.21 8
2021 Q1 732,914 $46,809,000 -$2,916,809 $63.86 8
2020 Q4 778,585 $44,573,000 -$935,612 $57.25 8
2020 Q3 794,928 $49,941,000 -$456,947 $62.82 8
2020 Q2 885,361 $51,034,000 -$568,564 $57.64 12
2020 Q1 895,225 $40,791,000 +$29,517 $45.57 12
2019 Q4 894,577 $43,655,000 -$445,716 $48.8 12
2019 Q3 903,710 $37,897,000 +$21,842 $41.94 12
2019 Q2 903,189 $41,991,000 -$278,644 $46.49 12
2019 Q1 909,181 $41,705,000 +$772,573 $45.87 12
2018 Q4 892,335 $39,740,000 -$1,132,942 $44.54 12
2018 Q3 917,771 $50,227,000 +$15,880 $54.72 12
2018 Q2 917,479 $46,478,000 -$415,832 $50.66 12
2018 Q1 925,687 $47,715,000 -$1,863,522 $51.55 12
2017 Q4 961,837 $54,793,000 -$794,194 $56.97 12
2017 Q3 975,792 $49,969,000 +$13,351 $51.21 12
2017 Q2 975,530 $42,694,000 +$910,265 $43.76 12
2017 Q1 954,751 $37,842,000 +$1,417,957 $39.63 11
2016 Q4 918,976 $31,685,000 +$34,128 $34.48 11
2016 Q3 917,992 $40,378,000 +$1,143,900 $43.99 11
2016 Q2 891,994 $42,903,000 +$845,501 $48.1 11
2016 Q1 874,414 $39,308,000 +$749,739 $44.95 11
2015 Q4 857,736 $41,297,000 +$2,227,278 $48.15 11
2015 Q3 827,241 $36,040,000 +$569,008 $43.57 9
2015 Q2 814,181 $38,704,000 +$233,736 $47.54 9
2015 Q1 809,265 $37,037,000 +$2,451,249 $45.77 9
2014 Q4 802,689 $33,881,000 +$47,217 $42.21 10
2014 Q3 801,582 $34,781,000 +$34,620 $43.39 10
2014 Q2 800,782 $40,167,000 -$739,161 $50.16 10
2014 Q1 815,517 $35,862,000 +$73,691 $43.97 10